Gallium-doped mesoporous bioactive glass nanoparticles for antibacterial and immunomodulatory effects in vital pulp therapy
Source abstract
Abstract
Vital pulp therapy (VPT) is crucial for the self-repair and long-term retention of teeth with pulpitis. Here, we aimed to develop gallium-doped mesoporous bioactive glass nanoparticles (Ga-MBGNs) as a multifunctional pulp capping material for VPT. Ga-MBGNs were synthesized and systematically characterized, followed by evaluation of their antibacterial, immunomodulatory, and dentinogenic properties using in vitro and in vivo models. In vitro, Ga-MBGNs effectively inhibited endodontic pathogens and promoted odontoblastic differentiation of human dental pulp cells. Mechanistically, they attenuated inflammation by reducing reactive oxygen species, activating the NRF2-HO-1 pathway, and suppressing NF-κB signaling. In a mouse pulp capping model, Ga-MBGNs significantly induced reparative dentin formation, maintained pulp vitality, and reduced inflammation. In conclusion, Ga-MBGNs represent a promising multifunctional pulp capping material with antibacterial, immunomodulatory, and dentinogenic properties, providing a potential strategy for VPT. STATEMENT OF SIGNIFICANCE: Pulpitis remains difficult to treat because current biomaterials cannot simultaneously control infection, regulate inflammation, and induce true tissue repair. In this work, we developed gallium-doped mesoporous bioactive glass nanoparticles (Ga-MBGNs) that directly link material structure to biological function. Their mesoporous architecture enables sustained Ga³⁺ release, which in turn suppresses bacterial growth, reduces oxidative stress, and modulates immune activation through the NRF2/HO-1/NF-κB pathway. This controlled ion delivery also promotes odontogenic differentiation and dentin matrix formation, ultimately preserving pulp vitality in vivo. By integrating antimicrobial, immunoregulatory, and regenerative capabilities within a single nano-engineered platform, this study introduces a structurally defined and functionally active biomaterial with clear potential to advance vital pulp therapy and regenerative dental medicine.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Wound Healing and Treatments · Nanoparticles: synthesis and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Genome-wide association study of pulpal and apical diseases10.1038/s41467-025-61721-1 ↗
2. Global burden of dental caries from 1990 to 2021 and future projections10.1016/j.identj.2025.100904 ↗
3. Prevalence of root canal treatment worldwide: a systematic review and meta-analysis10.1111/iej.13822 ↗
4. European Society of Endodontology position statement: management of deep caries and the exposed pulp10.1111/iej.13080 ↗
5. Outcomes and predictive factors of vital pulp therapy in a large-scale retrospective cohort study over 10 years10.1038/s41598-024-52654-8 ↗
6. Present status and future directions-vital pulp treatment and pulp preservation strategies10.1111/iej.13688 ↗
7. Discriminatory performance of the pulpal inflammatory biomarkers; interleukin-8 and TNF-α in patients with symptoms indicative of reversible and irreversible pulpitis: a diagnostic accuracy study10.1111/iej.14078 ↗
8. Inflammatory response mechanisms of the dentine-pulp complex and the periapical tissues10.3390/ijms22031480 ↗
9. SrCuSi4 O10 /GelMA composite hydrogel-mediated vital pulp therapy: integrating antibacterial property and enhanced pulp regeneration activity
10. In vitro and in vivo evaluation of a nanoparticulate bioceramic paste for dental pulp repair10.1016/j.actbio.2014.08.014 ↗
11. Mineral trioxide aggregate (MTA) and calcium hydroxide as pulp-capping agents in human teeth: a preliminary report10.1046/j.1365-2591.2003.00652.x ↗
12. Efficacy of biodentine and mineral trioxide aggregate in primary molar pulpotomies-A systematic review and meta-analysis with trial sequential analysis of randomized clinical trials10.1016/j.jebdp.2018.05.002 ↗
13. Novel L-(CaP-ZnP)/SA nanocomposite hydrogel with dual anti-inflammatory and mineralization effects for efficient vital pulp therapy10.2147/IJN.S464871 ↗
14. Comparing effectiveness of mineral trioxide aggregate, bioceramic putty and tannic acid in maintaining pulp vitality after experimental pulpotomy in rats10.1038/s41598-024-80601-0 ↗
15. Gallium-containing mesoporous nanoparticles influence in-vitro osteogenic and osteoclastic activity10.1016/j.bioadv.2024.213922 ↗
16. Antibacterial-osteogenic integrated liquid metal nanomedicine for periodontitis treatment10.1016/j.celbio.2024.100009 ↗
17. Ultrasmall Ga-ICG nanoparticles based gallium ion/photodynamic synergistic therapy to eradicate biofilms and against drug-resistant bacterial liver abscess
18. Gene expression analysis of gallium-resistant and gallium-sensitive lymphoma cells reveals a role for metal-responsive transcription factor-1, metallothionein-2A, and zinc transporter-1 in modulating the antineoplastic activity of gallium nitrate10.1158/1535-7163.MCT-06-0557 ↗
19. Thiol-ene photoclick hydrogels reinforced with poly(protocatechualdehyde)-coated gallium doped bioactive glass nanoparticles for scarless healing of infected wound10.1016/j.biomaterials.2025.123469 ↗
20. Erythrocyte-mimicking nanovesicle targeting Porphyromonas gingivalis for periodontitis10.1021/acsnano.4c02316 ↗
21. Antioxidative and antibacterial gallium (III)-phenolic coating for enhanced osseointegration of titanium implants via pro-osteogenesis and inhibiting osteoclastogenesis10.1016/j.biomaterials.2023.122268 ↗
22. Gallium nanodroplets are anti-inflammatory without interfering with iron homeostasis10.1021/acsnano.1c10981 ↗
23. Gallium-containing anticancer compounds10.4155/fmc.12.69 ↗
24. Developmental toxicity evaluation of gallium nitrate in mice10.1007/BF01974013 ↗
25. Advances in hybridized nanoarchitectures for improved oro-dental health10.1186/s12951-024-02680-5 ↗
26. Multifunctional mesoporous bioactive glasses for effective delivery of therapeutic ions and drug/growth factors10.1016/j.jconrel.2014.04.026 ↗
27. Bio-response of copper-magnesium co-substituted mesoporous bioactive glass for bone tissue regeneration10.1039/D3TB01568H ↗
28. Orchestrated tumor apoptosis (Cu2+) and bone tissue calcification (Ca2+) by hierarchical copper/calcium-ensembled bioactive silica for osteosarcoma therapy10.1016/j.cej.2022.134820 ↗
29. Anti-inflammatory cerium-containing nano-scaled mesoporous bioactive glass for promoting regenerative capability of dental pulp cells10.1111/iej.14055 ↗
30. Antimicrobial activity of calcium silicate-based dental materials: a literature review10.3390/antibiotics10070865 ↗
31. Dentinal tubule penetration of tricalcium silicate sealers10.1016/j.joen.2015.12.012 ↗
32. Application of nanomaterials in endodontics10.34133/bmef.0043 ↗
33. Particle size and shape analysis of MTA finer fractions using Portland cement10.1016/j.joen.2008.02.043 ↗
34. Tubule density and diameter in coronal dentin from primary and permanent human teeth
35. Dental pulp regeneration strategies: a review of status quo and recent advances
36. Gallium liquid metal: nanotoolbox for antimicrobial applications10.1021/acsnano.3c06486 ↗
37. Gallium-based metal-organic frameworks with antibacterial and anti-inflammatory properties for oral health protection
38. Effect of gallium on growth of Streptococcus mutans NCTC 10449 and dental tissues10.1159/000354048 ↗
39. Gallium and silver-doped titanium surfaces provide enhanced osteogenesis, reduce bone resorption and prevent bacterial infection in co-culture10.1016/j.actbio.2024.04.019 ↗
40. Evaluation of oxidative stress cycle in healthy and inflamed dental pulp tissue: a laboratory investigation10.1007/s00784-023-05203-y ↗
41. Role of oxidative stress in the induction of metallothionein-2A and heme oxygenase-1 gene expression by the antineoplastic agent gallium nitrate in human lymphoma cells10.1016/j.freeradbiomed.2008.05.031 ↗
42. Asiatic acid reduces lipopolysaccharides-induced pulp inflammation through activation of nuclear factor erythroid 2-related factor 2 in rats10.7717/peerj.18004 ↗
43. Targeting epigenetic and post-translational modifications of NRF2: key regulatory factors in disease treatment10.1038/s41420-025-02491-z ↗
44. Crosstalk of reactive oxygen species and NF-κb signaling10.1038/cr.2010.178 ↗
45. Curcumin protects against white matter injury through NF-κb and Nrf2 cross talk10.1089/neu.2019.6749 ↗